Home About Us Pipeline Investors News & Events Careers Contact Us
S*BIO Vision | Background | S*BIO Management | Board of Directors | Scientific Advisory Board | Corporate Values
Clinical Trials | R&D Programmes | Technologies & Capabilities | S*BIO’s Functional Capabilities | Publications
Investors | Partnerships
News & Press Releases | Participation in Events
Join Our Team | Job Openings | How to Apply

The best scientist is open to experience and begins with romance - the idea that anything is possible.
Ray Bradbury


News & Press Releases


10 December 2007 - S*BIO's Oral JAK-2 Inhibitor SB1518 Demonstrates Therapeutic Potential for the Treatment of Myeloproliferative and other Hematological Disorders
28 November 2007 - S*BIO Expands Pipeline with the Development of a Unique Flt3 – CDK Inhibitor as a Targeted Therapy for Acute Leukemias
11 September 2007 - S*BIO to Develop New JAK-2 Inhibitor for Treatment of Myeloproliferative Disorders and Hematological Malignancies
21 June 2007 - S*BIO Becomes Singapore's First Biotech Company to Initiate Clinical Trial of Novel Anti-Cancer Drug
29 May 2007 - S*BIO and National University Hospital-National University of Singapore Tissue Repository to Partner on Tumor Biomarker Research
7 February 2007 - S*BIO and A*STAR To Develop New Compounds To Treat Cancer
10 January 2007 - S*BIO Announces Research Collaboration with Karolinska Institutet
8 January 2007 - S*BIO Announces Incorporation of SBIO INC. and the Opening of US Operations



News & Press Releases Archive
2006 News & Press Releases
2005 News & Press Releases
2004 News & Press Releases
2003 News & Press Releases
2002 News & Press Releases
2001 News & Press Releases
2000 News & Press Releases

Back to top

Copyright © 2002 S*BIO Pte Ltd. All rights reserved.